MAPKによる上皮細胞の可塑性は,結腸直腸がんの治療抵抗を誘発する
Mark White1,2,3, Megan L Mills1,2, Laura M Millett1,2
1Cancer Research UK Scotland Institute, Glasgow, UK.
Nature
|November 25, 2025
まとめ
MAPK経路阻害剤は,幹細胞のような状態を促すことで耐性を引き起こします. 細胞の可塑性,特に初期またはWnt変異性腫瘍をターゲットにすることで,治療効果が向上する可能性があります.
科学分野:
- 腫瘍学
- 分子生物学
- 癌 研究
背景:
- 結腸直腸がん (CRC) は,腫瘍によって吸収される能力である急速な上皮再生を示します.
- KRASとBRAFの変異はCRCで一般的であり,MAPKシグナリングを活性化します.
- MAPK経路阻害剤はしばしば臨床抵抗に直面する.
研究 の 目的:
- 臨床前のCRCモデルにおけるMAPK標的治療に対する耐性のメカニズムを調査する.
- MAPKのシグナル伝達とその抑制が,CRCにおける上皮質の可塑性および幹細胞の表型にどのように影響するかを理解する.
- CRCの治療抵抗を克服する戦略を特定する.
主な方法:
- 先進的な結腸直腸がんモデルを使用した.
- 腫瘍性MAPKシグナリングによって誘発された in vivoの表皮状態の変化を分析した.
- MAPK経路の阻害に伴う転写再構成を検証した.
- 抑制された可塑性または特定の変異 (例えば,RNF43) を有するモデルにおける評価された治療反応.
主要な成果:
- 腫瘍性MAPKシグナリングは,CRC細胞を再生性,幹のような状態に駆り立てます.
- MAPKの阻害は迅速な転写変化を引き起こし,Wnt関連幹のフェノタイプを促進し,耐性を引き起こす.
- KRAS変異体では急性であり,BRAF変異体では遅い.
- プラスティシティを抑制したり,Wnt経路変異 (RNF43) を標的とした治療は,有意な治療効果をもたらした.
結論:
- 結腸直腸がんの治療反応には細胞の可塑性が重要です.
- MAPK阻害剤に対する耐性メカニズムの理解は,CRCの治療を改善するための鍵です.
- 幹細胞の運命と上皮の可塑性を標的とする戦略は,MAPK阻害剤の有効性を高めるのに有望である.
関連する概念動画
02:56Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
02:40Cancer Stem Cells and Tumor Maintenance
5.8K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.8K
02:07Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
02:38Mitogens and the Cell Cycle
7.7K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.7K
02:53Adaptive Mechanisms in Cancer Cells
6.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K
01:12Role Of Notch Signalling In Intestinal Stem Cell Renewal
2.4K
Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.4K